Emergence of biomarkers in nephropharmacology

Biomarkers in Medicine

Volumn 4, Issue 6, 2010, Pages 805-814

  Khan, Enver ^a,b   Batuman, Vecihi ^a,b   Lertora, Juan J L ^c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

biomarker; drug induced renal failure; kidney injury; nephrotoxins

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CADMIUM; CALCINEURIN INHIBITOR; CARBAPENEM; CISPLATIN; CREATININE; CYCLOSPORIN; CYSTATIN C; DOXORUBICIN; FATTY ACID BINDING PROTEIN; FOLIC ACID; GENTAMICIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 18; KIDNEY ANTIGEN; KIDNEY INJURY MOLECULE 1; LACTATE DEHYDROGENASE; MERCURY; N ACETYL BETA GLUCOSAMINIDASE; NETRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROGEN; RETINOL BINDING PROTEIN; TREFOIL PEPTIDE; UNINDEXED DRUG; UREA; VANCOMYCIN;

BLOOD ANALYSIS; CARDIOPULMONARY BYPASS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MODEL; EARLY DIAGNOSIS; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY INJURY; METABOLOMICS; MICROARRAY ANALYSIS; NEPHELOMETRY; NEPHROTOXICITY; NONHUMAN; PROTEOMICS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE VOLUME;

ACUTE KIDNEY INJURY; ANIMALS; BIOMARKERS, PHARMACOLOGICAL; DRUG TOXICITY; HUMANS; KIDNEY;

ANIMALIA;

EID: 78650717717     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.115     Document Type: Review

References (72)

1. Atkinson AJ Jr, Huang SM: Nephropharmacology: drugs and the kidney. Clin. Pharmacol. Ther. 86(5), 453-456 (2009).
2. Dreisbach AW: The infuence of chronic renal failure on drug metabolism and transport. Clin. Pharmacol. Ther. 86(5), 553-556 (2009).
3. Al-Ismaili Z, Palijan A, Zappitelli M: Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr. Nephrol. (2010) (Epub ahead of print).
4. Amin RP, Vickers AE, Sistare F et al.: Identifcation of putative gene based markers of renal toxicity. Environ. Health Perspect. 112(4), 465-479 (2004).
5. Beger RD, Sun J, Schnackenberg LK: Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol. Appl. Pharmacol. 243(2), 154-166 (2010).
6. Devarajan P: Proteomics for the investigation of acute kidney injury. Contrib. Nephrol. 160, 1-16 (2008).
7. Gibbs A: Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabonomic and proteomic methodologies. J. Appl. Toxicol. 25(4), 277-295 (2005).
8. Varghese SA, Powell TB, Janech MG et al.: Identifcation of diagnostic urinary biomarkers for acute kidney injury. J. Investig. Med. 58(4), 612-620 (2010).
9. Davis JW 2nd, Goodsaid FM, Bral CM et al.: Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 200(1), 16-26 (2004).
10. Che M, Xie B, Xue S et al.: Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron. Clin. Pract. 115(1), c66-c72 (2010).
11. Coca SG, Parikh CR: Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. 3(2), 481-490 (2008).
12. Dennen P, Parikh CR: Biomarkers of acute kidney injury: can we replace serum creatinine? Clin. Nephrol. 68(5), 269-278 (2007).
13. Devarajan P: Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin. Med. Diagn. 2(4), 387-398 (2008). (Pubitemid 351659225)
14. Liangos O, Tighiouart H, Perianayagam MC et al.: Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14(6), 423-431 (2009).
15. Liu KD, Altmann C, Smits G et al.: Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit. Care 13(4), R104 (2009).
16. Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratifcation of acute kidney injury: a systematic review. Kidney Int. 73(9), 1008-1016 (2008).
17. Goodsaid FM, Blank M, Dieterle F et al.: Novel biomarkers of acute kidney toxicity Clin. Pharmacol. Ther. 86(5), 490-496 (2009).
18. Dieterle F, Marrer E, Suzuki E, Grenet O, Cordier A, Vonderscher J: Monitoring kidney safety in drug development: emerging technologies and their implications. Curr. Opin. Drug Discov. Devel. 11(1), 60-71 (2008).
19. Haase-Fielitz A, Bellomo R, Devarajan P et al.: Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study Crit. Care Med. 37(2), 553-560 (2009).
20. McIlroy DR, Wagener G, Lee HT: Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 112(4), 998-1004 (2010).
21. Benohr P, Grenz A, Hartmann JT, Muller GA, Blaschke S: Cystatin C - a marker for assessment of the glomerular fltration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res. 29(1), 32-35 (2006).
22. Yashiro M, Kamata T, Segawa H, Kadoya Y, Murakami T, Muso E: Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease. Clin. Exp. Nephrol. 13(6), 598-604 (2009).
23. Xu H, Lu Y, Teng D, Wang J, Wang L, Li Y: Assessment of glomerular fltration rate in renal transplant patients using serum cystatin C. Transplant Proc. 38(7), 2006-2008 (2006).
24. Kniepeiss D, Wagner D, Wirnsberger G et al.: Serum cystatin C is an easy to obtain biomarker for the onset of renal impairment in heart transplant recipients. J. Thorac Cardiovasc. Surg. 140(3), 688-693 (2010).
25. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffeld JS, Bonventre JV: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118(5), 1657-1668 (2008).
26. Ichimura T, Bonventre JV, Bailly V et al.: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury J. Biol. Chem. 273(7), 4135-4142 (1998).
27. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury Am. J. Physiol. Renal Physiol. 286(3), F552-F563 (2004).
28. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (Kim-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237-244 (2002).
29. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV: Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 277(42), 39739-39748 (2002).
30. Zhang J, Brown RP, Shaw M et al.: Immunolocalization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distributions of iNOS and nitrotyrosine. Toxicol. P thol. 36(3), 397-409 (2008).
31. Zhang J, Goering PL, Espandiari P et al.: Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine. Toxicol. Pathol. 37(5), 629-643 (2009).
32. Zhang Z, Humphreys BD, Bonventre JV: Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J. Am. Soc. Nephrol. 18(10), 2704-2714 (2007).
33. Negishi K, Noiri E, Doi K et al.: Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am. J. Pathol. 174(4), 1154-1159 (2009).
34. Uehara T, Watanabe H, Itoh F et al.: Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch. Toxicol. 79(8), 451-460 (2005).
35. Sahni V, Choudhury D, Ahmed Z: Chemotherapy-associated renal dysfunction. Nat. Rev. Nephrol. 5(8), 450-462 (2009).
36. Tonomura Y, Tsuchiya N, Torii M, Uehara T: Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats. Toxicology 273 (1-3), 53-59 (2010).
37. Cristofori P, Zanetti E, Fregona D, Piaia A, Trevisan A: Renal proximal tubule segment-specific nephrotoxicity: an overview on biomarkers and histopathology. Toxicol. Pathol. 35(2), 270-275 (2007).
38. Rozell B, Hansson HA, Guthenberg C, Tahir MK, Mannervik B: Glutathione transferases of classes a, m and p show selective expression in different regions of rat kidney. Xenobiotica 23(8), 835-849 (1993).
39. Sieber M, Hoffmann D, Adler M et al.: Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol. Sci. 109(2), 336-349 (2009).
40. Vaidya VS, Ozer JS, Dieterle F et al.: Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualifcation studies. Nat. Biotechnol. 28(5), 478-485 (2010).
41. Zhou Y, Vaidya VS, Brown RP et al.: Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 101(1), 159-170 (2008).
42. Vaidya VS, Ford GM, Waikar SS et al.: A rapid urine test for early detection of kidney injury. Kidney Int. 76(1), 108-114 (2009).
43. Kjeldsen L, Cowland JB, Borregaard N: Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 1482(1-2), 272-283 (2000).
44. Mishra J, Ma Q, Prada A et al.: Identifcation of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14(10), 2534-2543 (2003).
45. Xu S, Venge P: Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta 1482(1-2), 298-307 (2000).
46. Cowland JB, Borregaard N: Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45(1), 17-23 (1997).
47. Gaspari F, Cravedi P, Mandala M et al.: Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron. Clin. Pract. 115(2), c154-c160 (2010).
48. Lisowska-Myjak B: Serum and urinary biomarkers of acute kidney injury. Blood Purif. 29(4), 357-365 (2010).
49. Haase M, Bellomo R, Devarajan P et al.: Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann. Thorac. Surg. 88(1), 124-130 (2009).
50. Ronco C, Grammaticopoulos S, Rosner M et al.: Oliguria, creatinine and other biomarkers of acute kidney injury. Contrib. Nephrol. 164, 118-127 (2010).
51. Soni SS, Ronco C, Katz N, Cruz DN: Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif. 28(3), 165-174 (2009).
52. Vaidya VS, Ferguson MA, Bonventre JV: Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493 (2008).
53. Faubel S, Lewis EC, Reznikov L et al.: Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1 b, IL-18, IL-6, and neutrophil infltration in the kidney J. Pharmacol. Exp. Ther. 322(1), 8-15 (2007).
54. Burdmann EA, Andoh TF, Lindsley J, Russell J, Bennett WM, Porter G: Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs. Ren. Fail. 16(1), 161-168 (1994).
55. Han WK, Waikar SS, Johnson A et al.: Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 73(7), 863-869 (2008).
56. Kurschel E, Metz-Kurschel U, Niederle N, Aulbert E: Investigations on the subclinical and clinical nephrotoxicity of interferon-a2B in patients with myeloproliferative syndromes. Ren. Fail. 13(2-3), 87-93 (1991).
57. Liangos O, Perianayagam MC, Vaidya VS et al.: Urinary N-acetyl-b-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18(3), 904-912 (2007).
58. Reeves WB, Kwon O, Ramesh G: Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury Am. J. Physiol. Renal Physiol. 294(4), F731-F738 (2008).
59. Basnakian AG: Netrin-1: a potential universal biomarker for acute kidney injury Am. J. Physiol. Renal Physiol. 294(4), F729-F730 (2008).
60. Ramesh G, Kwon O, Ahn K: Netrin-1: a novel universal biomarker of human kidney injury. Transplant Pro c. 42(5), 1519-1522 (2010).
61. Wang W, Reeves WB, Pays L, Mehlen P, Ramesh G: Netrin-1 overexpression protects kidney from ischemia reperfusion injury by suppressing apoptosis. Am. J. Pathol. 175(3), 1010-1018 (2009).
62. Valette JP, Nicot G, Charmes JP, Merle L, Benevent D, Leroux-Robert C: Low molecular weight proteins as urinary markers of aminoglycoside nephrotoxicity in man. Proc. Eur. Dial. Transplant Assoc. 16, 597-602 (1979).
63. Schentag JJ: Specifcity of renal tubular damage criteria for aminoglycoside nephrotoxicity in critically ill patients. J. Clin. Pharmacol. 23(10), 473-483 (1983).
64. Post FA, Moyle GJ, Stellbrink HJ et al.: Randomized comparison of renal effects, effcacy, and safety with once-daily abacavir/ lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study. J. Acquir. Immune Defc. Syndr. 55(1), 49-57 (2010).
65. Yu Y, Jin H, Holder D et al.: Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat. Biotechnol. 28(5), 470-477 (2010).
66. Ferguson MA, Vaidya VS, Bonventre JV: Biomarkers of nephrotoxic acute kidney injury. Toxicology 245(3), 182-193 (2008).
67. Waikar SS, Bonventre JV: Biomarkers for the diagnosis of acute kidney injury. Curr. Opin. Nephrol. Hypertens 16(6), 557-564 (2007).
68. Herget-Rosenthal S, Marggraf G, Husing J et al.: Early detection of acute renal failure by serum cystatin C. Kidney Int. 66(3), 1115-1122 (2004).
69. Dieterich C, Puey A, Lin S et al.: Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifes gene markers candidates. Toxicol. Sci. 107(1), 258-269 (2009).
70. Espandiari P, Zhang J, Rosenzweig BA et al.: The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. Toxicol. Sci. 99(2), 637-648 (2007).
71. Han WK, Wagener G, Zhu Y, Wang S, Lee HT: Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin. J. Am. Soc. Nephrol. 4(5), 873-882 (2009).
72. Wang W, Reeves WB, Ramesh G: Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor. Am. J. Physiol. Renal Physiol. 296(4), F723-F729 (2009).